Multiple myeloma: Revision history

11 December 2019

• curprev 02:4702:47, 11 December 2019‎ Rossdonaldson1 talk contribs‎ 5,194 bytes +37‎ →‎Differential Diagnosis

10 December 2019

• curprev 06:2106:21, 10 December 2019‎ Rossdonaldson1 talk contribs‎ 5,157 bytes +101‎ →‎Evaluation

20 November 2019

• curprev 22:3922:39, 20 November 2019‎ Mtjordan91 talk contribs‎ 5,056 bytes +91‎ →‎Evaluation
• curprev 22:3722:37, 20 November 2019‎ Mtjordan91 talk contribs‎ 4,965 bytes +259‎ →‎Evaluation
• curprev 22:3522:35, 20 November 2019‎ Mtjordan91 talk contribs‎ 4,706 bytes +97‎ →‎Evaluation
• curprev 22:3322:33, 20 November 2019‎ Mtjordan91 talk contribs‎ 4,609 bytes +49‎ →‎Clinical Features
• curprev 22:3222:32, 20 November 2019‎ Mtjordan91 talk contribs‎ 4,560 bytes +75‎ →‎Clinical Features
• curprev 22:3022:30, 20 November 2019‎ Mtjordan91 talk contribs‎ 4,485 bytes +63‎ →‎Clinical Features
• curprev 22:2922:29, 20 November 2019‎ Mtjordan91 talk contribs‎ 4,422 bytes +51‎ →‎Background
• curprev 22:2822:28, 20 November 2019‎ Mtjordan91 talk contribs‎ 4,371 bytes +110‎ →‎Background
• curprev 22:2622:26, 20 November 2019‎ Mtjordan91 talk contribs‎ 4,261 bytes +42‎ →‎Clinical Features
• curprev 22:2422:24, 20 November 2019‎ Mtjordan91 talk contribs‎ 4,219 bytes +38‎ →‎Background

2 October 2019

• curprev 22:4122:41, 2 October 2019‎ ClaireLewis talk contribs‎ 4,181 bytes +4‎ →‎Management

1 October 2019

• curprev 04:5404:54, 1 October 2019‎ ClaireLewis talk contribs‎ 4,177 bytes +66‎ No edit summary

18 January 2017

• curprev 22:1722:17, 18 January 2017‎ Kxl328 talk contribs‎ 4,111 bytes 0‎ →‎Clinical Features
• curprev 22:1622:16, 18 January 2017‎ Kxl328 talk contribs‎ 4,111 bytes +708‎ No edit summary
• curprev 22:1222:12, 18 January 2017‎ Kxl328 talk contribs‎ 3,403 bytes +144‎ No edit summary
• curprev 22:0922:09, 18 January 2017‎ Kxl328 talk contribs‎ 3,259 bytes +41‎ No edit summary
• curprev 22:0922:09, 18 January 2017‎ Kxl328 talk contribs‎ 3,218 bytes +15‎ No edit summary
• curprev 22:0822:08, 18 January 2017‎ Kxl328 talk contribs‎ 3,203 bytes −1‎ →‎Clinical Features
• curprev 22:0822:08, 18 January 2017‎ Kxl328 talk contribs‎ 3,204 bytes +2‎ No edit summary

11 December 2016

• curprev 00:1300:13, 11 December 2016‎ ClaireLewis talk contribs‎ 3,202 bytes +108‎ →‎Evaluation

6 December 2016

• curprev 00:5400:54, 6 December 2016‎ Alvarez13 talk contribs‎ 3,094 bytes +15‎ No edit summary
• curprev 00:5400:54, 6 December 2016‎ Alvarez13 talk contribs‎ 3,079 bytes +207‎ No edit summary
• curprev 00:5000:50, 6 December 2016‎ Alvarez13 talk contribs‎ 2,872 bytes +84‎ No edit summary

10 August 2016

• curprev 18:1618:16, 10 August 2016‎ ClaireLewis talk contribs‎ 2,788 bytes +94‎ No edit summary

17 July 2016

• curprev 15:1015:10, 17 July 2016‎ Neil.m.young talk contribs‎ 2,694 bytes +118‎ No edit summary

16 July 2016

• curprev 23:5923:59, 16 July 2016‎ ClaireLewis talk contribs‎ 2,576 bytes +23‎ No edit summary
• curprev 04:1004:10, 16 July 2016‎ Neil.m.young talk contribs‎ 2,553 bytes −6‎ No edit summary
• curprev 04:0904:09, 16 July 2016‎ Neil.m.young talk contribs‎ 2,559 bytes −1‎ No edit summary
• curprev 02:2502:25, 16 July 2016‎ ClaireLewis talk contribs‎ 2,560 bytes +1‎ →‎Management

• curprev 02:2402:24, 16 July 2016‎ ClaireLewis talk contribs‎ 2,559 bytes +2,559‎ Created page with "==Background== *Malignant proliferation of plasma cells overproduction of abnormal antibodies (paraproteins or light-chain protein) *Symptoms result from accumulation of plas..."